Antisense nucleic acids

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10329319
APP PUB NO 20170320903A1
SERIAL NO

15619996

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene. Also provided is a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NIPPON SHINYAKU CO LTD14 KISSHOIN NISHINOSHO MONGUCHICHO MINAMI-KU KYOTO-SHI KYOTO 6018550 ?6018550
NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY4-1-1 OGAWAHIGASHI-CHO KODAIRA-SHI TOKYO 1878551 ?1878551

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nagata, Tetsuya Kodaira, JP 155 1907
Satou, Youhei Tsukuba, JP 26 269
Takeda, Shin'ichi Kodaira, JP 44 503
Watanabe, Naoki Tsukuba, JP 375 4361

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 25, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 25, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00